Clinomics Inc.
KOSDAQ:A352770 Stock Report
Clinomics Balance Sheet Health
Financial Health criteria checks 2/6 Clinomics has a total shareholder equity of ₩44.6B and total debt of ₩32.8B, which brings its debt-to-equity ratio to 73.6%. Its total assets and total liabilities are ₩105.7B and ₩61.1B respectively.
Key information
73.6%
Debt to equity ratio
Interest coverage ratio n/a Cash ₩6.63b Equity ₩44.57b Total liabilities ₩61.13b Total assets ₩105.70b
Recent financial health updates
Show all updates
New major risk - Financial position Nov 09
New major risk - Share price stability Sep 10 Clinomics Inc. has completed a Follow-on Equity Offering in the amount of KRW 999.999932 million. May 30
Clinomics Inc. has completed a Follow-on Equity Offering in the amount of KRW 999.999932 million. May 29
Clinomics Inc. has filed a Follow-on Equity Offering in the amount of KRW 999.999932 million. May 19
Clinomics Inc. announced that it has received KRW 4 billion in funding May 18
Benign Growth For Clinomics Inc. (KOSDAQ:352770) Underpins Stock's 33% Plummet Mar 15
New major risk - Revenue and earnings growth Nov 30
New major risk - Share price stability Oct 30
New major risk - Shareholder dilution Sep 07
New minor risk - Shareholder dilution Jun 15
Full year 2022 earnings released: ₩768 loss per share (vs ₩1,214 profit in FY 2021) Mar 26
Investor sentiment improves as stock rises 23% Feb 02 Clinomics Inc. announced that it expects to receive KRW 2.99999694 billion in funding Dec 02
Investor sentiment improved over the past week Nov 07
Investor sentiment deteriorated over the past week Oct 13
Investor sentiment improved over the past week Jul 28
Investor sentiment improved over the past week Jul 11
Investor sentiment deteriorated over the past week Jun 23
Third quarter 2021 earnings released: EPS ₩354 (vs ₩289 loss in 3Q 2020) Nov 16
Clinomics Inc., Annual General Meeting, Mar 24, 2021 Feb 22
Financial Position Analysis
Short Term Liabilities: A352770's short term assets (₩21.1B) do not cover its short term liabilities (₩51.1B).
Long Term Liabilities: A352770's short term assets (₩21.1B) exceed its long term liabilities (₩10.0B).
Debt to Equity History and Analysis
Debt Level: A352770's net debt to equity ratio (58.7%) is considered high .
Reducing Debt: A352770's debt to equity ratio has reduced from 214.8% to 73.6% over the past 5 years.
Cash Runway Analysis For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A352770 has less than a year of cash runway based on its current free cash flow .
Forecast Cash Runway: A352770 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 11.6% each year
Discover healthy companies Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
